{"schema_version":"secwatch.filing_event.v1","accession":"0001401708-24-000036","form_type":"8-K","ticker":null,"cik":"0001401708","company_name":"NS Wind Down Co., Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.066284+00:00","generated_at":"2026-06-04T22:57:47.329006+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"NanoString agrees to sell substantially all assets to Patient Square for $220M in Chapter 11 sale","bullets":["Patient Square Capital serves as stalking-horse bidder; $220M cash plus assumption of certain liabilities.","Break-up fee of $6.6M and expense reimbursement up to $3.3M payable if alternative transaction accepted.","Court hearing to approve bidding procedures set for March 28, 2024; competing bids due by April 12.","Sale subject to Bankruptcy Court approval, HSR waiting period, and other customary conditions.","Company in Chapter 11 since Feb 4, 2024; common stock now trades OTC under NSTGQ."],"urls":{"canonical":"https://secwatch.observer/filing/0001401708-24-000036","json":"https://secwatch.observer/filing/0001401708-24-000036.json","markdown":"https://secwatch.observer/filing/0001401708-24-000036.md","text":"https://secwatch.observer/filing/0001401708-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000036/0001401708-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000036/nstg-20240310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:57:47.329006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed56032b07e4cc078c3af4ac47aa6c4238e9b686","claim":"NS Wind Down Co., Inc. entered into Asset Purchase Agreement with an affiliate of Patient Square Capital valued at $220,000,000 (effective 2024-03-10).","evidence_excerpt":"On March 10, 2024, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with an affiliate of Patient Square Capital (“Patient Square”) to sell substantially all of the assets of the Company and its subsidiaries (the “Business”) for a cash purchase price of $220,000,000 (the “Purchase Price”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401708/000140170824000036/0001401708-24-000036-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"an affiliate of Patient Square Capital"},{"label":"Value","value":"$220,000,000"},{"label":"Effective","value":"2024-03-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}